Journal
JOURNAL OF IMMUNOLOGY
Volume 175, Issue 5, Pages 3053-3059Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.175.5.3053
Keywords
-
Categories
Funding
- NIAID NIH HHS [U19 AI56388] Funding Source: Medline
- NIDDK NIH HHS [P30 DK63720] Funding Source: Medline
Ask authors/readers for more resources
CD(4+)CD25(+)Foxp(3+) regulatory T cells (T-reg) are critical for controlling autoinummity. Evidence suggests that T-reg development, peripheral maintenance, and suppressive function are dependent on Ag specificity. However, there is little direct evidence that the T-reg responsible for controlling autoimmunity in NOD mice or other natural settings are Ag specific. In fact, some investigators have argued that polyclonal Ag-nonspecific T-reg are efficient regulators of immunity. Thus, the goal of this study was to identify, expand, and characterize islet Ag-specific T-reg in NOD mice. Ag-specific Treg from NOD mice were efficiently expanded in vitro using IL-2 and beads coated with recombinant islet peptide mimic-MHC class II and anti-CD28 mAb. The expanded Ag-specific T-reg expressed prototypic surface markers and cytokines. Although activated in an Ag-specific fashion, the expanded T-reg were capable of bystander suppression both in vitro and in vivo. Importantly, the islet peptide mimic-specific T-reg were more efficient than polyclonal Treg in suppressing autoimmune diabetes. These results provide a direct demonstration of the presence of autoantigen-specific T-reg in the natural setting that can be applied as therapeutics for organ-specific autoimmunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available